Form 8-K Fibrocell Science, Inc. For: Jun 08

Go back to Form 8-K Fibrocell Science, Inc. For: Jun 08

Roth Affirms Fibrocell Science (FCSC) at 'Buy' Following Azficel-T Phase 2 Miss in Vocal Cord Scarring

June 8, 2016 11:59 AM EDT

Roth Capital affirms Fibrocell Science, Inc. (Nasdaq: FCSC) at Buy with a price target of $5 after the company announced that primary endpoints were not... More